Summit Therapeutics Inc. (SMMT)

NASDAQ: SMMT · Real-Time Price · USD

15.46

-0.62 (-3.86%)

At close: Mar 12, 2026, 4:00 PM EDT

15.43

-0.03 (-0.19%)

After-hours: Mar 12, 2026, 7:58 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Jan '19 Jan 31, 2019	Jan '18 Jan 31, 2018	Jan '17 Jan 31, 2017
Drug Development				705.00K	1.81M	860.00K	810.55K	57.09M
Drug Development Growth				-61.03%	110.35%	6.10%	-98.58%	183.69%
Total				705.00K	1.81M	860.00K	810.55K	57.09M
Total Growth				-61.03%	110.35%	6.10%	-98.58%	183.69%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Jan '19 Jan 31, 2019	Jan '18 Jan 31, 2018	Jan '17 Jan 31, 2017
United States				-	-	-	174.55K	56.10M
United States Growth				-	-	-	-99.69%	228.92%
Latin America				-	1.81M	860.00K	636.00K	662.00K
Latin America Growth				-	110.35%	35.22%	-3.93%	1009.73%
Europe				-	-	-	-	327.00K
Europe Growth				-	-	-	-	-25.73%
Total				-	1.81M	860.00K	810.55K	57.09M
Total Growth				-	110.35%	6.10%	-98.58%	225.19%

Source: S&P Global Market Intelligence.